Source comparison
Melanotan-1 vs MT-1: Functional Comparison
Amino Acid Sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Identical 13-amino-acid structure. No molecular difference Melanocortin Receptor Binding Selective MC1R agonist with minimal MC3R/MC4R activity Same receptor profile and binding a
This comparison does not assign a generated winner or score.
- Amino Acid Sequence
- Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
- Identical 13-amino-acid structure. No molecular difference
- Melanocortin Receptor Binding
- Selective MC1R agonist with minimal MC3R/MC4R activity
- Same receptor profile and binding affinity
- Half-Life Under Physiological Conditions
- Approximately 30–60 minutes following subcutaneous administration
- Equivalent pharmacokinetic stability
- Melanogenesis Mechanism
- Stimulates cAMP-dependent eumelanin synthesis in melanocytes
- Identical intracellular signalling cascade
- Synthesis Method
- Solid-phase peptide synthesis (SPPS) using Fmoc chemistry
- Same production protocol regardless of supplier label
- Storage Requirements
- Store lyophilised powder at −20°C; reconstituted solution at 2–8°C, use within 28 days
- No naming-dependent storage distinction